GENinCode (LON:GENI – Get Free Report) released its quarterly earnings results on Tuesday. The company reported GBX (0.38) earnings per share (EPS) for the quarter, Digital Look Earnings reports. GENinCode had a negative net margin of 202.42% and a negative return on equity of 481.34%.
GENinCode Trading Up 5.0%
GENinCode stock traded up GBX 0.04 during trading on Thursday, hitting GBX 0.73. The company had a trading volume of 2,103,826 shares, compared to its average volume of 5,110,390. GENinCode has a 1-year low of GBX 0.64 and a 1-year high of GBX 4.90. The company has a current ratio of 2.22, a quick ratio of 15.88 and a debt-to-equity ratio of 4.75. The company’s 50 day simple moving average is GBX 0.88 and its 200-day simple moving average is GBX 0.98. The stock has a market cap of £5.53 million, a price-to-earnings ratio of -0.35 and a beta of 0.59.
GENinCode Company Profile
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Featured Articles
- Five stocks we like better than GENinCode
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
